Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer.
Journal
Lung cancer (Amsterdam, Netherlands)
Journal Volume
200
Start Page
論文號碼 108076
ISSN
1872-8332
Date Issued
2025-02
Author(s)
Saw, Stephanie P L
Zhong, Wen-Zhao
Fu, Rui
Li, Molly S C
Goto, Yasushi
Fox, Stephen B
Yatabe, Yasushi
Ong, Boon-Hean
Ng, Calvin S H
Lee, David D W
Cam Phuong, Pham
Park, In Kyu
Tsuboi, Masahiro
Tho, Lye Mun
John, Thomas
Tan, Daniel S W
Mok, Tony S K
Reungwetwattana, Thanyanan
Singh, Navneet
Abstract
The peri-operative management of non-small cell lung cancer (NSCLC) in earlier stage disease has seen significant advances in recent years with the incorporation of immune checkpoint inhibitors and targeted therapy. However, many unanswered questions and challenges remain, including the application of clinical trial data to routine clinical practice. Recognising the unique demographic profile of Asian patients with NSCLC and heterogeneous healthcare systems, the Asian Thoracic Oncology Research Group (ATORG) convened a consensus meeting in Singapore on 26 April 2024 to discuss relevant issues spanning diagnostic testing to post-neoadjuvant treatment considerations and future directions. An interdisciplinary group of 19 experts comprising medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists and pathologists from Singapore, Hong Kong, Mainland China, Korea, Japan, Taiwan, India, Malaysia, Thailand, Vietnam and Australia met to discuss emerging data, identify existing gaps in clinical care and develop a multidisciplinary, multinational expert consensus statement on the peri-operative management of NSCLC tailored to the Asia-Pacific region.
Subjects
Asian
Consensus statement
NSCLC
Peri-operative
Publisher
Elsevier Ireland Ltd
Type
review